# MT-ATP8

## Overview
The MT-ATP8 gene is a mitochondrial gene that encodes the protein known as mitochondrially encoded ATP synthase membrane subunit 8. This protein is a critical component of the ATP synthase complex, specifically within the F_O domain, and plays a structural role in the mitochondrial oxidative phosphorylation system. As a transmembrane protein, subunit 8 is involved in maintaining the stability and integrity of the ATP synthase complex by interacting with other subunits, such as subunit a, which is essential for proton transport and ATP synthesis. Although subunit 8 does not directly participate in proton transport, its structural role is vital for the proper functioning of the enzyme complex, which is crucial for cellular energy production (Panja2023Analysis). Variants in the MT-ATP8 gene have been associated with several mitochondrial disorders, highlighting its clinical significance (Del2024Variants).

## Structure
The MT-ATP8 gene encodes a subunit of ATP synthase, which is part of the mitochondrial oxidative phosphorylation system. The protein encoded by MT-ATP8 is a small hydrophilic polypeptide consisting of 68 amino acids, playing a structural role by connecting the membrane portion of the enzyme with the F1 catalytic domain (Del2024Variants). The primary sequence of subunit 8 is not highly conserved across species, but its structure in the membrane domain is preserved, allowing for modeling of substitutions (Panja2023Analysis).

In terms of secondary structure, subunit 8 forms an α-helix that spans the membrane and is associated with other stator subunits of the ATP synthase complex (Rucheton2020Homoplasmic). This α-helix is crucial for maintaining the structural integrity of the enzyme complex. The tertiary structure of subunit 8 involves its interaction with neighboring residues, which is essential for the stability and function of ATP synthase (Panja2023Analysis).

The quaternary structure of subunit 8 involves its integration into the ATP synthase complex, where it is part of the stator, contributing to the overall stability and function of the enzyme (Panja2023Analysis). Specific amino acid substitutions in subunit 8 can affect its hydrophobic interactions and stability, potentially leading to mitochondrial diseases (Panja2023Analysis).

## Function
The MT-ATP8 gene encodes subunit 8 of the ATP synthase enzyme, which is a crucial component of the oxidative phosphorylation system in mitochondria. This system is essential for ATP production, the primary energy currency in cells (Panja2023Analysis). Subunit 8 is part of the F_O domain of ATP synthase and plays a structural role by stabilizing the positioning of subunit a within the membrane domain, which is critical for the proper functioning of the proton channel and ATP synthesis (Panja2023Analysis).

Although subunit 8 is not directly involved in proton transport, it is adjacent to subunit a, which is involved in this process, and helps maintain hydrophobic interactions with subunits a and j (Panja2023Analysis). These interactions are essential for the stability and function of ATP synthase, ensuring efficient ATP production in healthy cells (Panja2023Analysis). The MT-ATP8 gene's role in maintaining the structural integrity of ATP synthase is vital for cellular energy metabolism and overall organismal energy homeostasis (Del2024Variants).

## Clinical Significance
Mutations in the MT-ATP8 gene, which encodes a subunit of ATP synthase, are associated with a variety of mitochondrial disorders. These disorders often manifest as neuromuscular and metabolic conditions due to impaired ATP production. Specific variants in MT-ATP8 have been linked to diseases such as Maternally-Inherited Diabetes and Deafness (MIDD), Left Ventricular Non-Compaction (LVNC) cardiomyopathy, episodic paralysis, and severe mitochondrial disorders (Panja2023Analysis). The m.8418T>C and m.8424T>C variants are particularly noted for their potential pathogenicity, as they can significantly decrease oxygen consumption and ATP production, leading to mitochondrial diseases (Panja2023Analysis).

The MT-ATP8 gene variants can also cause sensitivity to certain medications. For instance, the mt.8393C>T variant has been associated with valproic acid sensitivity, leading to severe neurological symptoms in affected individuals (De2018Reversible). The clinical manifestations of these variants can vary significantly, influenced by factors such as heteroplasmy, nuclear background, and mt-DNA haplogroup (Del2024Variants). Despite the challenges in treatment, therapeutic strategies are being explored, including gene therapy approaches and antioxidant therapies to mitigate the effects of these mutations (Del2024Variants).

## Interactions
The MT-ATP8 gene encodes subunit 8 of the ATP synthase complex, which is a crucial component of the oxidative phosphorylation system in mitochondria. Subunit 8 is part of the stator in the F_O domain of ATP synthase and plays a significant role in maintaining the structural stability of the enzyme complex, although it is not directly involved in proton transfer (Panja2023Analysis). 

MT-ATP8 interacts with other subunits within the ATP synthase complex, particularly subunit a, which is involved in proton transfer. These interactions are essential for the proper assembly and function of the enzyme complex. Variants in MT-ATP8 can lead to structural changes that affect its interaction with subunit a and other components, potentially destabilizing the enzyme and impairing ATP synthesis (Rucheton2020Homoplasmic). 

The MT-ATP8 protein forms an α-helix that spans the mitochondrial membrane and is associated with other stator subunits, contributing to the overall stability and function of the ATP synthase complex (Rucheton2020Homoplasmic). These interactions highlight the importance of MT-ATP8 in maintaining the integrity and efficiency of mitochondrial energy production.


## References


[1. (Panja2023Analysis) Chiranjit Panja, Katarzyna Niedzwiecka, Emilia Baranowska, Jaroslaw Poznanski, and Roza Kucharczyk. Analysis of mt-atp8 gene variants reported in patients by modeling in silico and in yeast model organism. Scientific Reports, June 2023. URL: http://dx.doi.org/10.1038/s41598-023-36637-9, doi:10.1038/s41598-023-36637-9. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-36637-9)

[2. (Del2024Variants) Valentina Del Dotto, Francesco Musiani, Alessandra Baracca, and Giancarlo Solaini. Variants in human atp synthase mitochondrial genes: biochemical dysfunctions, associated diseases, and therapies. International Journal of Molecular Sciences, 25(4):2239, February 2024. URL: http://dx.doi.org/10.3390/ijms25042239, doi:10.3390/ijms25042239. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25042239)

[3. (Rucheton2020Homoplasmic) Benoit Rucheton, Claude Jardel, Sandrine Filaut, Maria del Mar Amador, Thierry Maisonobe, Isabelle Serre, Norma Beatriz Romero, Sarah Leonard-Louis, Francis Haraux, and Anne Lombès. Homoplasmic deleterious mt-atp6/8 mutations in adult patients. Mitochondrion, 55:64–77, November 2020. URL: http://dx.doi.org/10.1016/j.mito.2020.08.004, doi:10.1016/j.mito.2020.08.004. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mito.2020.08.004)

[4. (De2018Reversible) Giovanna De Michele, Pierpaolo Sorrentino, Claudia Nesti, Anna Rubegni, Lucia Ruggiero, Silvio Peluso, Antonella Antenora, Mario Quarantelli, Alessandro Filla, Giuseppe De Michele, and Filippo M. Santorelli. Reversible valproate-induced subacute encephalopathy associated with a mt-atp8 variant in the mitochondrial genome. Frontiers in Neurology, August 2018. URL: http://dx.doi.org/10.3389/fneur.2018.00728, doi:10.3389/fneur.2018.00728. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2018.00728)